Chapter 30: Pituitary Drugs
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The pituitary gland operates within a neuroendocrine feedback system where hypothalamic control coordinates anterior and posterior lobe secretions to regulate growth, metabolism, reproduction, and fluid homeostasis. Anterior pituitary drugs include cosyntropin, a synthetic adrenocorticotropic hormone analog used diagnostically to assess adrenal reserve and responsiveness; somatropin, a recombinant growth hormone replacement for growth disorders and cachexia syndromes; and octreotide, a somatostatin analog that suppresses excessive growth hormone in acromegaly while controlling neuroendocrine tumor symptoms including carcinoid syndrome and vasoactive intestinal peptide secretion. Posterior pituitary agents consist of vasopressin and desmopressin, which are synthetic vasopressin derivatives that restore water reabsorption in central diabetes insipidus, manage acute hemorrhage from portal hypertension, and improve hemostasis in von Willebrand disease and hemophilia A by enhancing factor VIII and von Willebrand factor release. The chapter details mechanism of action, therapeutic indications, contraindications, and adverse effect profiles ranging from hypertension and fluid retention with vasopressin to metabolic complications such as hyperglycemia and hypothyroidism with somatropin, plus cardiac arrhythmias with octreotide. Drug interactions with agents like carbamazepine, lithium, and certain psychotropics require monitoring for altered efficacy or toxicity. Nursing practice emphasizes comprehensive baseline assessment including anthropometric measurements, metabolic markers, cardiovascular parameters, and growth trajectory evaluation in pediatric populations. Clinical monitoring focuses on fluid and electrolyte balance, blood pressure trends, glucose regulation, and symptom resolution or emergence. Patient education addresses correct administration technique across intranasal, subcutaneous, intramuscular, and intravenous routes, medication adherence strategies, recognition of adverse effects requiring immediate reporting, and maintenance of medical alert identification for emergency responders.